
What has to happen between a promising research paper and a biotech company someone is willing to fund?
Bodo Brückner joins Pierre Jacob and Meronn Jacob to explain how the Life Science Accelerator Baden-Württemberg helps teams work toward investment readiness, and what scientists need to understand when they start building a business.
Bodo describes an entrepreneurship course in which students take a real scientific paper, imagine they own its intellectual property, and develop a business model to pitch. That exercise opens up a bigger discussion: who needs the technology, what risks remain, and which milestones could make it more valuable to a potential partner or investor?
We also discuss his path from molecular biology to supporting startups, his view of Europe's funding challenges, and why observing needs in hospitals can be a starting point for innovation. On AI, Bodo shares both his interest in its potential and his skepticism about sweeping promises to solve biology on a short timeline.
In this conversation:
◼️ What an accelerator does to help life science teams become investment ready
◼️ Bodo's move from research into consulting and startup support
◼️ His perspective on early funding, scale-up capital, and repeat founders
◼️ Teaching scientists to build a business case from a research paper
◼️ Intellectual property, milestones, and reducing uncertainty
◼️ AI expectations and the complexity of biology
◼️ Learning from clinical needs and connecting startups with hospitals
◼️ Understanding the business side without rushing out of science
Transcribed Podcast: in-person interviews with scientists, founders, and industry experts shaping the future of biotech and pharma.
New episodes every Tuesday at 16:00 (Europe/Berlin).
🎙️ Watch all episodes: https://www.youtube.com/@TranscribedPod
📥 Free Biotech Starter Pack: https://transcribedpod.com
📸 Instagram: @transcribedpod
📧 [email protected]
🎵 Jingle composed by Tembeh: https://open.spotify.com/artist/4s9JmadJjVdYQ6YxYtJgja
⚠️ Disclaimer: For information and education only. Not medical, financial, investment, tax or legal advice. Guests share their own experiences and opinions, not necessarily those of Transcribed or its hosts. Nothing here is a recommendation to start, stop or change any treatment, supplement or investment; consult a qualified professional about your own situation. Mentions of companies or products are not endorsements, and Transcribed accepts no liability for decisions based on this content.
00:00 Welcome and introducing Bodo Brückner
01:02 What does a life science accelerator do?
02:53 Measuring investment readiness
03:59 From molecular biology to supporting startups
08:06 Europe's funding and scale-up challenge
11:03 Repeat founders and building experience
13:55 What Bodo looks for in founder teams
15:20 Free Biotech Starter Pack
15:36 Building a business from a research paper
19:35 Technology, intellectual property, and milestones
22:03 AI expectations meet biological complexity
27:17 Competition, markets, and data across Europe
28:36 Starting with needs in hospitals
30:45 Advice for scientists considering entrepreneurship
32:02 Learning the business side and staying curious
Weitere Episoden von „Transcribed“



Verpasse keine Episode von “Transcribed” und abonniere ihn in der kostenlosen GetPodcast App.








